Gensight Biologics SA
PAR:SIGHT

Watchlist Manager

Gensight Biologics SA

PAR:SIGHT

Watchlist

Dividends

Discount Rate

Price: 0.3185 EUR 1.92% Market Closed

Market Cap: 36.7m EUR

Have any thoughts about
Gensight Biologics SA?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US		Fubotv Inc NYSE:FUBO	Media
US		Bank of America Corp NYSE:BAC	Banking
US		Palantir Technologies Inc NYSE:PLTR	Technology
US	C	C3.ai Inc NYSE:AI	Technology
US		Uber Technologies Inc NYSE:UBER	Road & Rail
CN		NIO Inc NYSE:NIO	Automobiles
US		Fluor Corp NYSE:FLR	Construction
US		Jacobs Engineering Group Inc NYSE:J	Professional Services
US		TopBuild Corp NYSE:BLD	Consumer products
US		Abbott Laboratories NYSE:ABT	Health Care
US		Chevron Corp NYSE:CVX	Energy
US		Occidental Petroleum Corp NYSE:OXY	Energy
US		Matrix Service Co NASDAQ:MTRX	Construction
US		Automatic Data Processing Inc NASDAQ:ADP	Technology
US		Qualcomm Inc NASDAQ:QCOM	Semiconductors
US		Ambarella Inc NASDAQ:AMBA	Semiconductors

Add Price Alert

Price Target:

Last Price: 0.3185 EUR

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

SIGHT Alert

Gensight Biologics SA

0.3185

+0.0060 (+1.92%)

52 Week Range	0.2815 0.522
Price Target

We'll email you a reminder when the closing price reaches EUR.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Fubotv Inc NYSE:FUBO	US
	Bank of America Corp NYSE:BAC	US
	Palantir Technologies Inc NYSE:PLTR	US
C	C3.ai Inc NYSE:AI	US
	Uber Technologies Inc NYSE:UBER	US
	NIO Inc NYSE:NIO	CN
	Fluor Corp NYSE:FLR	US
	Jacobs Engineering Group Inc NYSE:J	US
	TopBuild Corp NYSE:BLD	US
	Abbott Laboratories NYSE:ABT	US
	Chevron Corp NYSE:CVX	US
	Occidental Petroleum Corp NYSE:OXY	US
	Matrix Service Co NASDAQ:MTRX	US
	Automatic Data Processing Inc NASDAQ:ADP	US
	Qualcomm Inc NASDAQ:QCOM	US
	Ambarella Inc NASDAQ:AMBA	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Gensight Biologics SA

What unique competitive advantages
does Gensight Biologics SA hold over its rivals?

What risks and challenges
does Gensight Biologics SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Gensight Biologics SA.

What unique competitive advantages
does Gensight Biologics SA hold over its rivals?

What risks and challenges
does Gensight Biologics SA face in the near future?

Has there been any significant insider trading activity
in Gensight Biologics SA recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Gensight Biologics SA.

Provide P/S
for Gensight Biologics SA.

Provide P/E
for Gensight Biologics SA.

Provide P/OCF
for Gensight Biologics SA.

Provide P/FCFE
for Gensight Biologics SA.

Provide P/B
for Gensight Biologics SA.

Provide EV/S
for Gensight Biologics SA.

Provide EV/GP
for Gensight Biologics SA.

Provide EV/EBITDA
for Gensight Biologics SA.

Provide EV/EBIT
for Gensight Biologics SA.

Provide EV/OCF
for Gensight Biologics SA.

Provide EV/FCFF
for Gensight Biologics SA.

Provide EV/IC
for Gensight Biologics SA.

Show me price targets
for Gensight Biologics SA made by professional analysts.

What are the Revenue projections
for Gensight Biologics SA?

How accurate were the past Revenue estimates
for Gensight Biologics SA?

What are the Net Income projections
for Gensight Biologics SA?

How accurate were the past Net Income estimates
for Gensight Biologics SA?

What are the EPS projections
for Gensight Biologics SA?

How accurate were the past EPS estimates
for Gensight Biologics SA?

What are the EBIT projections
for Gensight Biologics SA?

How accurate were the past EBIT estimates
for Gensight Biologics SA?

Compare the revenue forecasts
for Gensight Biologics SA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Gensight Biologics SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Gensight Biologics SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Gensight Biologics SA compared to its peers.

Compare the P/E ratios
of Gensight Biologics SA against its peers.

Discuss the investment returns and shareholder value creation
comparing Gensight Biologics SA with its peers.

Analyze the financial leverage
of Gensight Biologics SA compared to its main competitors.

Show all profitability ratios
for Gensight Biologics SA.

Provide ROE
for Gensight Biologics SA.

Provide ROA
for Gensight Biologics SA.

Provide ROIC
for Gensight Biologics SA.

Provide ROCE
for Gensight Biologics SA.

Provide Gross Margin
for Gensight Biologics SA.

Provide Operating Margin
for Gensight Biologics SA.

Provide Net Margin
for Gensight Biologics SA.

Provide FCF Margin
for Gensight Biologics SA.

Show all solvency ratios
for Gensight Biologics SA.

Provide D/E Ratio
for Gensight Biologics SA.

Provide D/A Ratio
for Gensight Biologics SA.

Provide Interest Coverage Ratio
for Gensight Biologics SA.

Provide Altman Z-Score Ratio
for Gensight Biologics SA.

Provide Quick Ratio
for Gensight Biologics SA.

Provide Current Ratio
for Gensight Biologics SA.

Provide Cash Ratio
for Gensight Biologics SA.

What is the historical Revenue growth
over the last 5 years for Gensight Biologics SA?

What is the historical Net Income growth
over the last 5 years for Gensight Biologics SA?

What is the current Free Cash Flow
of Gensight Biologics SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Gensight Biologics SA.

Section:

Wall Street
Price Targets

SIGHT Price Targets Summary
Gensight Biologics SA

Wall Street analysts forecast SIGHT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SIGHT is 0.3876 EUR with a low forecast of 0.3636 EUR and a high forecast of 0.42 EUR.

SIGHT Lowest Forecast

Wall Street Target

0.3636 EUR

14% Upside

SIGHT Average Forecast

Wall Street Target

0.3876 EUR

22% Upside

SIGHT Highest Forecast

Wall Street Target

0.42 EUR

32% Upside

Lowest

Price Target

0.3636 EUR

14% Upside

Average

Price Target

0.3876 EUR

22% Upside

Highest

Price Target

0.42 EUR

32% Upside

Gensight Biologics SA Competitors:
Price Targets

IOVA

Iovance Biotherapeutics Inc

182% Upside

SLRN

ACELYRIN Inc

158% Upside

9926

Akeso Inc

3% Upside

NVAX

Novavax Inc

107% Upside

IOVA

Iovance Biotherapeutics Inc

182% Upside

SLRN

ACELYRIN Inc

158% Upside

9926

Akeso Inc

3% Upside

NVAX

Novavax Inc

107% Upside

MAB

Mabion SA

13% Upside

CDTX

Cidara Therapeutics Inc

55% Upside

GILD

Gilead Sciences Inc

8% Upside

NTRA

Natera Inc

6% Upside

Revenue
Forecast

Revenue Estimate
Gensight Biologics SA

The compound annual growth rate of Gensight Biologics SA's revenue for the next 3 years is 32%.

N/A

Past Growth

32%

Estimated Growth

Estimates Accuracy

-54%

Average Miss

What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Gensight Biologics SA

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

Average Beat

What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Gensight Biologics SA

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

-70%

Average Miss

What are analyst estimates?

What is SIGHT's stock price target?

Price Target
0.3876 EUR

According to Wall Street analysts, the average 1-year price target for SIGHT is 0.3876 EUR with a low forecast of 0.3636 EUR and a high forecast of 0.42 EUR.

What is Gensight Biologics SA's Revenue forecast?

Projected CAGR
32%

The compound annual growth rate of Gensight Biologics SA's revenue for the next 3 years is 32%.

Gensight Biologics SA
PAR:SIGHT

Wall Street
Price Targets

SIGHT Price Targets Summary
Gensight Biologics SA

Revenue
Forecast

Revenue Estimate
Gensight Biologics SA

Operating Income
Forecast

Operating Income Estimate
Gensight Biologics SA

Net Income
Forecast

Net Income Estimate
Gensight Biologics SA

See Also

What is SIGHT's stock price target?

Price Target
0.3876 EUR

What is Gensight Biologics SA's Revenue forecast?

Projected CAGR
32%

Company

Help

Tools

Stocks

Gensight Biologics SA PAR:SIGHT

Wall Street Price Targets

SIGHT Price Targets Summary Gensight Biologics SA

Revenue Forecast

Revenue Estimate Gensight Biologics SA

Operating Income Forecast

Operating Income Estimate Gensight Biologics SA

Net Income Forecast

Net Income Estimate Gensight Biologics SA

See Also

What is SIGHT's stock price target? Price Target 0.3876 EUR

What is Gensight Biologics SA's Revenue forecast? Projected CAGR 32%

Company

Help

Tools

Stocks

Gensight Biologics SA
PAR:SIGHT

Wall Street
Price Targets

SIGHT Price Targets Summary
Gensight Biologics SA

Revenue
Forecast

Revenue Estimate
Gensight Biologics SA

Operating Income
Forecast

Operating Income Estimate
Gensight Biologics SA

Net Income
Forecast

Net Income Estimate
Gensight Biologics SA

What is SIGHT's stock price target?

Price Target
0.3876 EUR

What is Gensight Biologics SA's Revenue forecast?

Projected CAGR
32%